Cargando…
Strategies for Improving the Efficacy of CAR T Cells in Solid Cancers
SIMPLE SUMMARY: Cell therapy with genetically retargeted T cells shows strong clinical efficacy against leukaemia and lymphoma. To make this therapy efficient against solid cancers, a series of hurdles must be addressed. This includes the need to enable the T cells to survive long term in patients a...
Autor principal: | Kyte, Jon Amund |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833730/ https://www.ncbi.nlm.nih.gov/pubmed/35158839 http://dx.doi.org/10.3390/cancers14030571 |
Ejemplares similares
-
New Strategies for the Treatment of Solid Tumors with CAR-T Cells
por: Zhang, Hao, et al.
Publicado: (2016) -
Gene modification strategies for next-generation CAR T cells against solid cancers
por: Tian, Yonggui, et al.
Publicado: (2020) -
Efficacy, Safety, and Challenges of CAR T-Cells in the Treatment of Solid Tumors
por: Chen, Qiuqiang, et al.
Publicado: (2022) -
S79. CAR strategies in solid tumours
por: Rossig, C
Publicado: (2014) -
CAR-T with License to Kill Solid Tumors in Search of a Winning Strategy
por: Sacchetti, Benedetto, et al.
Publicado: (2019)